Aandelen in “Productie van biologische producten”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Productie van biologische producten”

25/05 · GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026   · Persbericht

25/05 · GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026   · Persbericht

22/05 · Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

22/05 · Biogen Inc. (BIIB) Securities Fraud Investigation - Levi & Korsinsky · Persbericht

21/05 · Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA · Persbericht

21/05 · GENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update · Persbericht

21/05 · ATRA EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 · Persbericht

20/05 · Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026 · Persbericht

20/05 · Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets · Persbericht

20/05 · Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky · Persbericht

20/05 · Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 22, 2026 to Discuss Your Rights - ATRA · Persbericht

19/05 · AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH · Persbericht

19/05 · Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes · Persbericht

18/05 · Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules · Persbericht

18/05 · REGENXBIO to Participate in Upcoming Investor Conferences · Persbericht

18/05 · BIIB SHAREHOLDER INVESTIGATION: SueWallSt Investigates Biogen Inc. for Possible Securities Law Violations · Persbericht

18/05 · Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics · Persbericht

16/05 · Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) · Persbericht

15/05 · Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA · Persbericht

14/05 · ATRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 · Persbericht

14/05 · REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights · Persbericht

Mijn selecties